Aeye, INC. 8-K Filing

Ticker: LIDRW · Form: 8-K · Filed: Dec 10, 2025 · CIK: 1818644

Sentiment: neutral

Filing Stats: 895 words · 4 min read · ~3 pages · Grade level 10.6 · Accepted 2025-12-10 17:01:19

Key Financial Figures

Filing Documents

02. Termination of a Material Definitive Agreement

Item 1.02. Termination of a Material Definitive Agreement. In support of its 2026 capital optimization objectives, on December 10, 2025, AEye, Inc. (the "Company") provided the required five trading day written notice to New Circle Principal Investments LLC ("New Circle") to effectuate the voluntary termination (the "Termination") of the Share Purchase Agreement, dated July 25, 2024, by and between the Company and New Circle (the "Share Purchase Agreement"), pursuant to which New Circle had committed to purchase, subject to certain limitations, up to $50 million of the Company's common stock. The Termination is expected to become effective on December 17, 2025. At the time the Company delivered the notice to terminate, and at the time of termination, there were no outstanding borrowings, advance notices or shares of common stock to be issued under the Share Purchase Agreement. In addition, no termination fees or other payments were due by either party in connection with the termination of the Share Purchase Agreement.

01. Other Events

Item 8.01. Other Events. To offset the loss of liquidity associated with the Termination and achieve a net increase in overall liquidity by approximately $28 million, on December 10, 2025, the Company filed Amendment No. 5 ("Amendment No. 5") to the Prospectus Supplements (as defined below) to increase the maximum number of shares of the Company's common stock (the "Placement Shares") issuable pursuant to the At Market Issuance Sales Agreement between the Company and A.G.P./Alliance Global Partners, dated September 12, 2024 (the "Sales Agreement"), by $50.0 million, which is reflected on Amendment No. 5 as an aggregate offering price of up to $125.0 million of Placement Shares and includes the shares of the Company's common stock having an aggregate gross sales price of approximately $68.4 million that were sold pursuant to the Prospectus Supplements to date. The issuance and sale of the Placement Shares by the Company under the Sales Agreement will be made pursuant to the Company's registration statement on Form S-3 (File No. 333-274546) filed with the Securities and Exchange Commission on September 15, 2023, and declared effective on September 26, 2023, as supplemented and amended by the prospectus supplements, dated as of September 13, 2024 and December 30, 2024 (the "Prospectus Supplements"), Amendments No. 1, No. 2, No. 3, and No. 4 to the Prospectus Supplements, dated as of January 7, 2025, January 23, 2025, July 25, 2025, and July 28, 2025, respectively, and Amendment No 5. A copy of the legal opinion of Allen Overy Shearman Sterling US LLP relating to the Placement Shares is filed as Exhibit 5.1 hereto. This Current Report on Form 8-K shall not constitute an offer to sell or a solicitation of an offer to buy any shares of common stock in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

01. Financial Statement and Exhibits

Item 9.01. Financial Statement and Exhibits. (d) Exhibits. Exhibit Number Description 5.1 Opinion of Allen Overy Shearman Sterling US LLP. 23.1 Consent of Allen Overy Shearman Sterling US LLP (included in Exhibit 5.1). 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AEye, Inc. Dated: December 10, 2025 By: /s/ Andrew S. Hughes Andrew S. Hughes Senior Vice President, General Counsel & Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing